Novo Nordisk Launches Wegovy Pill in the US with Broad Availability
Novo Nordisk's Wegovy pill, the first and only oral GLP-1 for weight loss in adults, is now broadly available across America as of January 5, 2026.
Full US launch is prepared for early January 2026, with manufacturing underway in North Carolina facilities.
No confirmation in available sources of a $25 per month price for insured patients.